{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:21:56Z","timestamp":1791296516051,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ejphar.2008.04.039","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T12:04:30Z","timestamp":1208779470000},"page":"170-177","source":"Crossref","is-referenced-by-count":39,"title":["Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: A comparative study of coupling to G\u03b1s"],"prefix":"10.1016","volume":"588","author":[{"given":"Delphine S.","family":"Dupuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde Mannoury","family":"la Cour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chaput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Verri\u00e8le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Lavielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.04.039_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/FBP.0b013e3280ae6c96","article-title":"Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2\/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics","volume":"18","author":"Bardin","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib2","series-title":"Annual Meeting Society of Neuroscience, 567.13","article-title":"WAY-181187: neurochemical profile of a novel and selective 5-HT6 receptor agonist","author":"Beyer","year":"2005"},{"key":"10.1016\/j.ejphar.2008.04.039_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0028-3908(97)00019-1","article-title":"Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells","volume":"36","author":"Boess","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2008.04.039_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1021\/jm980532e","article-title":"5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist","volume":"42","author":"Bromidge","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2008.04.039_bib5","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.105.092155","article-title":"Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2\/D3 partial agonist","volume":"315","author":"Burstein","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.04.039_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0014-2999(01)01399-1","article-title":"Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine","volume":"430","author":"Bymaster","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl 7","key":"10.1016\/j.ejphar.2008.04.039_bib7","first-page":"4","article-title":"The pharmacology of weight gain with antipsychotics","volume":"62","author":"Casey","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2008.04.039_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/jm049243i","article-title":"Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists","volume":"48","author":"Cole","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2008.04.039_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1124\/mol.62.3.578","article-title":"Differential activation of Gq\/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking","volume":"62","author":"Cussac","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2003.11.077","article-title":"Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapine","volume":"485","author":"Cussac","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neures.2006.10.020","article-title":"Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors","volume":"57","author":"Dai","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejphar.2008.04.039_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1527-3458.2004.tb00030.x","article-title":"Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology","volume":"10","author":"Davies","year":"2004","journal-title":"CNS. Drug Rev."},{"key":"10.1016\/j.ejphar.2008.04.039_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bjp.0703288","article-title":"In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate","volume":"130","author":"Dawson","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib14","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0022-3565(24)38222-9","article-title":"Determination of [35S]guanosine-5\u2032-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay","volume":"289","author":"DeLapp","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.04.039_bib15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.bjp.0706807","article-title":"Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats","volume":"148","author":"Fisas","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.npp.1300332","article-title":"The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats","volume":"29","author":"Foley","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2008.04.039_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00213-007-0973-y","article-title":"Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia","volume":"196","author":"Franberg","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.04.039_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bmcl.2006.10.036","article-title":"Studies towards the identification of a new generation of atypical antipsychotic agents","volume":"17","author":"Garzya","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2008.04.039_bib19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF03401577","article-title":"Clozapine: selective labeling of sites resembling 5HT6 serotonin receptors may reflect psychoactive profile","volume":"1","author":"Glatt","year":"1995","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejphar.2008.04.039_bib20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/schbul\/sbi058","article-title":"Predicting drug efficacy for cognitive deficits in schizophrenia","volume":"31","author":"Hagan","year":"2005","journal-title":"Schizophr.Bull."},{"key":"10.1016\/j.ejphar.2008.04.039_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-005-2261-z","article-title":"5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats","volume":"181","author":"Hatcher","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.04.039_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.neuropharm.2006.11.008","article-title":"Differential agonist and inverse agonist profile of antipsychotics at D2L receptors coupled to GIRK potassium channels","volume":"52","author":"Heusler","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2008.04.039_bib23","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/sj.bjp.0703458","article-title":"Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue","volume":"130","author":"Hirst","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1124\/mol.64.6.1295","article-title":"Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling","volume":"64","author":"Hirst","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2006.09.049","article-title":"SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models","volume":"553","author":"Hirst","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0165-6147(93)90129-8","article-title":"Partial agonists, full agonists, antagonists: dilemmas of definition","volume":"14","author":"Hoyer","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2008.04.039_bib27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1359-6446(05)03491-4","article-title":"Dopamine D3 receptor antagonists as therapeutic agents","volume":"10","author":"Joyce","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2008.04.039_bib28","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbrc.2005.02.040","article-title":"Molecular analysis of the interaction between the intracellular loops of the human serotonin receptor type 6 (5-HT6) and the alpha subunit of GS protein","volume":"329","author":"Kang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2008.04.039_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0169-328X(01)00034-1","article-title":"Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain","volume":"88","author":"Kinsey","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ejphar.2008.04.039_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1471-4159.1996.66010047.x","article-title":"Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor","volume":"66","author":"Kohen","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2008.04.039_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/syn.10288","article-title":"5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex","volume":"51","author":"Lacroix","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2008.04.039_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-6147(93)90018-F","article-title":"Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng\u2013Prusoff equation","volume":"14","author":"Lazareno","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2008.04.039_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0091-3057(03)00082-0","article-title":"Effect of the 5-HT6 receptor antagonists Ro04-6790 and Ro65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine","volume":"75","author":"Leng","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2008.04.039_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2006.11.060","article-title":"5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus","volume":"1134","author":"Li","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.04.039_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00213-007-0934-5","article-title":"Pro-cognitive effects of 5-HT(6) receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex","volume":"196","author":"Loiseau","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.04.039_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2202-7-36","article-title":"Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients","volume":"7","author":"Lorke","year":"2006","journal-title":"BMC. Neurosci."},{"key":"10.1016\/j.ejphar.2008.04.039_bib37","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.neuropharm.2006.10.021","article-title":"Dopamine D1 receptor coupling to Gs\/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)\/antibody-capture characterization of benzazepine agonists","volume":"52","author":"Mannoury","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2008.04.039_bib38","doi-asserted-by":"crossref","unstructured":"Mannoury, l.C., Herbelles, C., Pasteau, V., de Nanteuil, G., Millan, M.J., 2008. Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes. J. Neurochem. 105, 308\u2013323.","DOI":"10.1111\/j.1471-4159.2007.05131.x"},{"key":"10.1016\/j.ejphar.2008.04.039_bib39","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1460-9568.2006.05003.x","article-title":"Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release","volume":"24","author":"Marcos","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2008.04.039_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(99)00636-6","article-title":"Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex","volume":"383","author":"Matsumoto","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib41","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2008.04.039_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbr.2006.11.048","article-title":"Memory consolidation and amnesia modify 5-HT6 receptors expression in rat brain: an autoradiographic study","volume":"178","author":"Meneses","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2008.04.039_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jneumeth.2006.09.011","article-title":"Dimethyl sulfoxide: an antagonist in scintillation proximity assay [(35)S]-GTPgammaS binding to rat 5-HT(6) receptor cloned in HEK-293 cells?","volume":"160","author":"Mereghetti","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2008.04.039_bib44","first-page":"853","article-title":"Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors","volume":"295","author":"Millan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.04.039_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2008.04.039_bib47","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0022-3565(24)37731-6","volume":"286","author":"Millan","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.04.039_bib48","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0022-3565(24)37732-8","volume":"286","author":"Millan","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.04.039_bib49","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00213-006-0567-0","volume":"191","author":"Millan","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.04.039_bib50","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pharmthera.2005.05.001","article-title":"5-HT6 receptors: a novel target for cognitive enhancement","volume":"108","author":"Mitchell","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2008.04.039_bib51","first-page":"320","article-title":"Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs","volume":"43","author":"Monsma","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib52","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/sj.npp.1301279","article-title":"Evaluation of N-desmethylclozapine as a potential antipsychotic-preclinical studies","volume":"32","author":"Natesan","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 18","key":"10.1016\/j.ejphar.2008.04.039_bib53","first-page":"36","article-title":"Abnormalities of glucose metabolism associated with atypical antipsychotic drugs","volume":"65","author":"Newcomer","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2008.04.039_bib54","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/mol.62.3.590","article-title":"Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling","volume":"62","author":"Newman-Tancredi","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib55","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1017\/S1461145704005000","article-title":"Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia","volume":"8","author":"Newman-Tancredi","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2007.04660.x","article-title":"Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation","author":"Novi","year":"2007","journal-title":"J Neurochem."},{"key":"10.1016\/j.ejphar.2008.04.039_bib57","series-title":"A superior Antipsychotic: Rational Design or Irrational Dream? Drugs Future. 19th Int Symp Med Chem, Istanbul 31 L33","author":"Payne","year":"2006"},{"key":"10.1016\/j.ejphar.2008.04.039_bib58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0091-3057(01)00743-2","article-title":"Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia","volume":"71","author":"Pouzet","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2008.04.039_bib59","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/syn.10157","article-title":"Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor","volume":"47","author":"Purohit","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2008.04.039_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2008.04.039_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-8993(02)02360-0","article-title":"The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585","volume":"934","author":"Roberts","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.04.039_bib62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002130100840","article-title":"5-HT6 receptor antagonists enhance retention of a water maze task in the rat","volume":"158","author":"Rogers","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.04.039_bib63","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.bjp.0706827","article-title":"Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways","volume":"148","author":"Romero","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib64","first-page":"1403","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Roth","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.04.039_bib65","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/sj.bjp.0703457","article-title":"Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist","volume":"130","author":"Routledge","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib66","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/bbrc.1993.1619","article-title":"A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation","volume":"193","author":"Ruat","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2008.04.039_bib67","series-title":"Annual Meeting Society of Neuroscience 394.11","article-title":"Pharmacological profile of a novel and selective 5-HT6 receptor agonist: WAY-466","author":"Schechter","year":"2004"},{"key":"10.1016\/j.ejphar.2008.04.039_bib68","article-title":"Neuropharmacological profile of novel and selective 5-HT(6) Receptor Agonists: WAY-181187 and WAY-208466","author":"Schechter","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2008.04.039_bib69","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.euroneuro.2006.06.009","article-title":"Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating","volume":"17","author":"Schreiber","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib70","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1097\/00001756-199412000-00037","article-title":"5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture","volume":"5","author":"Sebben","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2008.04.039_bib71","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","article-title":"Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat","volume":"26","author":"Shirazi-Southall","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2008.04.039_bib72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1358\/mf.2005.27.5.908643","article-title":"Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes","volume":"27","author":"Silvestre","year":"2005","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib73","doi-asserted-by":"crossref","first-page":"13674","DOI":"10.1073\/pnas.1835612100","article-title":"N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-d-aspartate receptor activity","volume":"100","author":"Sur","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ejphar.2008.04.039_bib74","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1523\/JNEUROSCI.3110-06.2007","article-title":"Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation","volume":"27","author":"Svenningsson","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2008.04.039_bib75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1568007024606195","article-title":"Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis","volume":"1","author":"Tamminga","year":"2002","journal-title":"Curr. Drug Targets. CNS. Neurol. Disord."},{"key":"10.1016\/j.ejphar.2008.04.039_bib76","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0304-3940(99)00802-2","article-title":"Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease","volume":"276","author":"Tsai","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2008.04.039_bib77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.npp.1301071","article-title":"Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways","volume":"32","author":"Urban","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2008.04.039_bib78","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neuropharm.2004.10.013","article-title":"Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties","volume":"48","author":"Urwyler","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2008.04.039_bib79","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2-R","article-title":"Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum","volume":"370","author":"Ward","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2008.04.039_bib80","article-title":"Effects of the brain-penetrant and selective 5-HT(6) receptor antagonist SB-399885 in animal models of anxiety and depression","author":"Wesolowska","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2008.04.039_bib81","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00056-9","article-title":"A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze","volume":"41","author":"Woolley","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2008.04.039_bib82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007043482561","article-title":"5-ht6 receptors","volume":"3","author":"Woolley","year":"2004","journal-title":"Curr. Drug Targets. CNS. Neurol. Disord."},{"key":"10.1016\/j.ejphar.2008.04.039_bib83","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0169-328X(97)00026-0","article-title":"Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus","volume":"45","author":"Yau","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ejphar.2008.04.039_bib84","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0024-3205(98)00092-7","article-title":"Central distribution and function of 5-HT6 receptor subtype in the rat brain","volume":"62","author":"Yoshioka","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2008.04.039_bib85","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1074\/jbc.M606215200","article-title":"The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn","volume":"282","author":"Yun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.04.039_bib86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(03)01855-7","article-title":"Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein","volume":"472","author":"Zhang","year":"2003","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908004688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908004688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T20:59:30Z","timestamp":1738184370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908004688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":86,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0014299908004688"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.04.039","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}